| Title |
Author |
Type |
Date |
Words |
| Research and Markets: Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution. |
|
|
May 31, 2012 |
393 |
| Research and Markets: Generics in Cardiovascular Diseases Market to 2018 Report - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution. |
|
Report |
May 30, 2012 |
411 |
| Actavis Launches Generic Equivalent of Adalat CC 90mg (Nifedipine Extended-Release Tablets, USP). |
|
|
May 30, 2012 |
401 |
| Mylan Launches Generic Version of Lipitor. |
|
|
May 29, 2012 |
432 |
| Watson Announces Lidoderm Patent Challenge Settlement. |
|
|
May 29, 2012 |
1072 |
| Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex. |
|
|
May 29, 2012 |
567 |
| New cautions about long-term use of bone drugs. |
|
|
May 26, 2012 |
483 |
| Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration. |
|
|
May 25, 2012 |
691 |
| Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40. |
|
|
May 24, 2012 |
1134 |
| Medochemie Ltd Rapidly Deploys Cegedim Relationship Management's Award Winning*, Cloud-Based Mobile Intelligence and World Leading OneKey[TM] Database to Drive Growth in Key Markets. |
|
Company overview |
May 24, 2012 |
748 |
| Mylan Launches Generic Version of Bonviva Film Coated Tablets in the UK and Italy. |
|
|
May 24, 2012 |
444 |
| Mylan Launches Generic Version of Bonviva Film Coated Tablets in the UK and Italy. |
|
|
May 24, 2012 |
403 |
| Moody's Upgrades Mylan. |
|
|
May 23, 2012 |
637 |
| New Zoning to Highlight High-Growth Sectors at China Pharma Events. |
|
|
May 23, 2012 |
1014 |
| P-MEC China and Co-Located Shows Provide Access to Growing Markets and Debut Zoning. |
|
|
May 23, 2012 |
911 |
| Mylan Launches Generic Version of Viramune Tablets. |
|
|
May 23, 2012 |
468 |
| Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as Plavix[R] Loses Patent Protection. |
|
|
May 22, 2012 |
729 |
| Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan. |
|
|
May 22, 2012 |
320 |
| Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream. |
|
|
May 22, 2012 |
665 |
| Research and Markets: Comparisons of Pharmaceutical Manufacturing between China and India - The Two Most Dynamic Emerging Countries. |
|
|
May 21, 2012 |
1138 |
| Noven Confirms Filing of Abbreviated New Drug Application for Generic Lidocaine Patch 5%. |
|
|
May 21, 2012 |
309 |
| Actavis Launches First Generic Equivalent of Requip XL (Ropinirole Extended-Release Tablets). |
|
|
May 18, 2012 |
442 |
| Watson Confirms Lo Loestrin Fe Patent Challenge. |
|
|
May 18, 2012 |
836 |
| Dr. Reddy's Announces the Launch of Clopidogrel Tablets, USP. |
|
|
May 18, 2012 |
465 |
| Research and Markets: Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion. |
|
|
May 18, 2012 |
403 |
| Mylan Launches Generic Version of Plavix Tablets. |
|
|
May 17, 2012 |
582 |
| Amneal Upgrades Generic Metformin Family by Listening to Customers. |
|
|
May 16, 2012 |
703 |
| Walgreens Launches New and Improved Prescription Savings Club as Approximately 1 in 4 U.S. Adults Lack Adequate Prescription Drug Coverage. |
|
|
May 15, 2012 |
1297 |
| European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan. |
|
|
May 14, 2012 |
745 |
| European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan. |
|
|
May 14, 2012 |
729 |
| Mylan Launches Generic Lipitor in Five European Countries. |
|
|
May 11, 2012 |
409 |
| Mylan Launches Generic Lipitor in Five European Countries. |
|
|
May 11, 2012 |
404 |
| Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion. |
|
|
May 10, 2012 |
4979 |
| Use of Bristol-Myers Squibb's Oral Abilify is Shifting to First-Line Treatment of Newly Diagnosed Schizophrenia Patients. |
|
|
May 9, 2012 |
506 |
| Teva UK Limited Launches Generic Atorvastatin Tablets in Four Strengths. |
|
|
May 8, 2012 |
554 |
| Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc. |
|
|
May 8, 2012 |
493 |
| Indian drug giant Cipla slashes cancer drug prices. |
|
|
May 4, 2012 |
539 |
| In Mexico, New Guidelines Are Now in Effect for the Market Authorization of Biologics and Biosimilars Called Biocomparables. |
|
|
May 2, 2012 |
714 |
| Teva settles Nuvigil litigation with Mylan. |
|
|
Apr 30, 2012 |
811 |
| Research and Markets: Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market. |
|
|
Apr 30, 2012 |
400 |
| Dr. Reddy's Announces the Launch of Olanzapine Tablets. |
|
|
Apr 24, 2012 |
453 |
| US Supreme Court ruling supports generic drug makers. |
|
|
Apr 18, 2012 |
330 |
| Research and Markets: Pharmaceutical Reformulation Strategies - New Technologies Extend Use Beyond Lifecycle Management. |
|
|
Apr 18, 2012 |
454 |
| "Smoking Cessation Drugs Market Will Reach $2.4 Billion in 2012" Visiongain Report Predicts. |
|
|
Apr 16, 2012 |
465 |
| Impax Laboratories Confirms Patent Challenge Relating to Generic GRALISE[R] 300 mg and 600 mg. |
|
|
Apr 12, 2012 |
877 |
| The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Securities Laws Violations by ViroPharma Inc. |
|
|
Apr 11, 2012 |
291 |
| Akorn Announces the Approval and Launch of Generic Vancocin[R]. |
|
|
Apr 10, 2012 |
579 |
| FDA Decides Teva is Sole First-to-File on Provigil[R]. |
|
|
Apr 5, 2012 |
729 |
| Research and Markets: Health Care Provider Job Descriptions. |
|
|
Apr 4, 2012 |
223 |
| Teva Announces Launch of Generic Avapro[R] and Generic Avalide[R] in the United States; Awarded 180-Day Period of Marketing Exclusivity. |
|
|
Apr 2, 2012 |
732 |
| Biosimilarity benchmarks: FDA guidance marks first step toward an expedited pathway for generic biotech drugs. |
Maleske, Melissa |
|
Apr 1, 2012 |
1266 |
| Generic form of escitalopram is ok'd by FDA. |
Mechcatie, Elizabeth |
|
Apr 1, 2012 |
116 |
| India sets precedent for overcoming drug price barriers. |
Bateman, Chris |
|
Apr 1, 2012 |
556 |
| Israel,United Kingdom,United States : Mylan and Teva unveil generic versions of antipsychotic Seroquel. |
|
|
Mar 31, 2012 |
101 |
| Teva Announces Launch of Authorized Generic of Provigil[R]. |
|
|
Mar 30, 2012 |
723 |
| Research and Markets: Generics in Japan. |
|
|
Mar 29, 2012 |
413 |
| Dr. Reddy's Announces the Launch of Quetiapine Fumarate Tablets. |
|
|
Mar 28, 2012 |
440 |
| In 2015, Nanoparticle Paclitaxel in Combination with Carboplatin Will Earn Decision Resources' Proprietary Clinical Gold Standard Status for First-Line Advanced Squamous Non-Small-Cell Lung Cancer. |
|
|
Mar 28, 2012 |
710 |
| Teva Announces Launch of Generic Seroquel[R] in the United States. |
|
|
Mar 28, 2012 |
690 |
| Federman & Sherwood Announces Investigation of Recall by Glenmark Generics, Inc. USA. |
|
|
Mar 27, 2012 |
640 |
| Comprehensive Ophthalmologists and Glaucoma Specialists Are Either Prescribing Generic Latanoprost in Place of Pfizer's Xalatan or Switching Patients to Alcon's Travatan Z or Allergan's Lumigan, According to a Recent BioTrends Report. |
|
|
Mar 26, 2012 |
718 |
| Research and Markets: Top Ten ANDA / PARA-IV / API Opportunities To Be Targeted By Generic or Active Pharmaceutical Ingredient Companies. |
|
|
Mar 21, 2012 |
316 |
| Teva Pharmaceutical Industries Ltd. to Transfer Listing to NYSE. |
|
|
Mar 21, 2012 |
907 |
| Research and Markets: Portal Hypertension Therapeutics: Pipeline Assessment and Market Forecasts to 2019. |
|
|
Mar 15, 2012 |
445 |
| Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of BYSTOLIC[R] Patent. |
|
|
Mar 14, 2012 |
416 |
| Teva Announces Launch of Generic Lexapro[R] in the United States; Awarded 180-Day Period of Marketing Exclusivity. |
|
|
Mar 14, 2012 |
726 |
| Amneal Launches Escitalopram Oxalate Oral Solution. |
|
|
Mar 14, 2012 |
414 |
| A cheap drug for cancer in India soon. |
|
|
Mar 13, 2012 |
370 |
| Cypin Production's Branded Generics Conference Attracts Unexpected Breadth of Attendees. |
|
Conference news |
Mar 9, 2012 |
344 |
| Dr. Reddy's Announces the Launch of Ziprasidone Hydrochloride Capsules. |
|
|
Mar 3, 2012 |
396 |
| Teva Announces Launch of Generic Prometrium[R] Capsules in the United States. |
|
|
Mar 2, 2012 |
719 |
| Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study. |
Jarratt, Michael T.; Brundage, Tom |
Report |
Mar 1, 2012 |
4544 |
| Three key antipsychotics lose patent protection: state medicaid programs, patients to save as major atypical meds "go generic". |
Albright, Brian |
|
Mar 1, 2012 |
1494 |
| Research and Markets: China's Guidebook for Pharmaceutical Patent Protection: An Essential Resource for Overseas and Multinational Pharmaceutical Companies. |
|
|
Feb 29, 2012 |
527 |
| Fitch: Near-Reality of Biosimilars a Minor Plus for U.S. Health Care. |
|
|
Feb 28, 2012 |
379 |
| In 2015, Gilead's GS-7977 Plus Ribavirin Will Earn Decision Resources' Proprietary Clinical Gold Standard Status for the Treatment of Non-Responder Patients with Hepatitis C Virus. |
|
|
Feb 28, 2012 |
749 |
| Surveyed U.S. Neurologists Indicate They Would Prescribe CoLucid's Lasmiditan to 10 Percent of Their Patients with Migraine. |
|
|
Feb 22, 2012 |
687 |
| Santarus and Depomed Announce Settlement with Lupin of GLUMETZA Patent Litigation. |
|
|
Feb 22, 2012 |
827 |
| Research and Markets: African Pharmaceutical Directory 2012 Covers the Entire African Pharmaceutical & Biotechnology Industries Sector. |
|
|
Feb 21, 2012 |
405 |
| A GENERIC version of one [...]. |
|
|
Feb 20, 2012 |
172 |
| Research and Markets: Pharmaceutical Directory of India 2012: Featuring Hundreds of Fresh Business Contacts. |
|
|
Feb 16, 2012 |
437 |
| Research and Markets: Japan Generics Market Analysis. |
|
|
Feb 16, 2012 |
402 |
| Part D spending gap pinned on brand names. |
Moon, Mary Ann |
|
Feb 15, 2012 |
597 |
| Teva UK Limited Launches Generic Donepezil Tablets and Donepezil OD Tablets. |
|
|
Feb 14, 2012 |
667 |
| Fitch: FDA Proposed Guidelines Open the Door to Biosimilars. |
|
|
Feb 10, 2012 |
607 |
| Mylan Receives Final FDA Approval for First Generic Version of Doryx[R] Tablets, 150 mg. |
|
|
Feb 9, 2012 |
564 |
| Teva UK Limited Launches Latanoprost + Timolol Eye Drops. |
|
|
Feb 8, 2012 |
487 |
| The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca. |
|
|
Feb 7, 2012 |
1716 |
| United Therapeutics Receives Paragraph IV Notice Letter for Remodulin. |
|
|
Feb 6, 2012 |
595 |
| Comparative MIC evaluation of a generic ceftriaxone by broth microdilution on clinically relevant isolates from an academic hospital complex in South Africa. |
Lowman, Warren; Aithma, Naseema; Coetzee, Johan F.; Duse, Adriano G.; Mer, Mervyn |
Report |
Feb 1, 2012 |
1541 |
| House dems examining ADHD Drug shortages. |
Anderson, Jane |
|
Feb 1, 2012 |
290 |
| TPI Receives Approval for High Tech Enterprise Status. |
|
|
Jan 31, 2012 |
403 |
| TPI Gets Approval for High Tech Enterprise Status. |
|
|
Jan 31, 2012 |
316 |
| Research and Markets: World Generic Markets. |
|
|
Jan 19, 2012 |
286 |
| Teva UK Limited Launches Latanoprost Eye Drops. |
|
|
Jan 18, 2012 |
541 |
| Research and Markets: Antidyslipidemics Market and Product Forecasts: Set for the Impact of Generic Lipitor. |
|
|
Jan 18, 2012 |
401 |
| Research and Markets: Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth. |
|
|
Jan 18, 2012 |
315 |
| Research and Markets: Osteoporosis - Prolia and Odanacatib to Restore Growth in the Market. |
|
|
Jan 17, 2012 |
420 |
| Research and Markets: Impact of Patent Expiry on Global Generic Drugs Market - Trends, Opportunities and Challenges Post 2011 Focuses On the Current Generics Market Globally and the Impact of Patent Expirations. |
|
Industry overview |
Jan 17, 2012 |
406 |
| Research and Markets: Flooded by Generics ENT Disorders Therapeutics Market to Witness Meager Growth. |
|
|
Jan 11, 2012 |
410 |
| India's generics flow into Africa. |
|
|
Jan 1, 2012 |
783 |
| Laminated high-barrier film. |
|
|
Jan 1, 2012 |
180 |
| A generic service architecture for secure ubiquitous computing systems. |
Chen, Shudong; Lukkien, Johan; Verhoeven, Richard |
Report |
Jan 1, 2012 |
9537 |
| TPI Receives Approval for High Tech Enterprise Status. |
|
|
Dec 30, 2011 |
600 |
| Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo. |
|
Industry overview |
Dec 29, 2011 |
1159 |
| Biosimilars Market Entry Strategies - For Pharma Companies, Biosimilars Offer a Relatively Low Risk Growth Strategy. |
|
|
Dec 26, 2011 |
563 |
| TPI Presents at the 2nd Annual OneMed China Forum on January 9th, 2012 in San Francisco. |
|
|
Dec 23, 2011 |
607 |
| Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe. |
|
|
Dec 22, 2011 |
941 |
| Actavis to Launch Novel Pain Medication in the US. |
|
|
Dec 21, 2011 |
975 |
| TPI Attends 30th J.P. Morgan Healthcare Conference at San Francisco. |
|
Conference news |
Dec 20, 2011 |
375 |
| Research and Markets: Peripheral Artery Disease (PAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - Market to reach $7422.3m by 2018. |
|
|
Dec 16, 2011 |
543 |
| Mylan Launches Generic Version of Toprol-XL Tablets. |
|
|
Dec 16, 2011 |
330 |
| The Current Market Leader in Epilepsy, Levetiracetam, Will Maintain Its Market-Leading Status Through 2020. |
|
|
Dec 13, 2011 |
551 |
| Through 2020, Generic Erosion of Blockbuster Agents Will Be a Major Contributor to a Nearly $6 Billion Decrease in the Dyslipidemia Drug Market. |
|
|
Dec 12, 2011 |
473 |
| Teva UK Limited Launches Generic Anti-obesity Drug Orlistat. |
|
|
Dec 9, 2011 |
521 |
| BlueCross Health Institute Addresses Rising Drug Costs. |
|
|
Dec 8, 2011 |
515 |
| Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion of Key Agents and Increased Product Competition. |
|
|
Dec 8, 2011 |
481 |
| Shionogi & Co., Ltd. and Shionogi Inc. Announce a Favorable Decision In FORTAMET[R] Preliminary Injunction Proceedings. |
|
|
Dec 7, 2011 |
631 |
| Ranbaxy Launches Authorized Generic Version of Caduet[R] In the U.S. |
|
Company overview |
Dec 6, 2011 |
476 |
| Despite the Generic Erosion of Key Agents, the Non-Small-Cell Lung Cancer Drug Market Will Increase 2.5 Percent Annually Between 2010 and 2020. |
|
|
Dec 5, 2011 |
872 |
| Upsher-Smith Launches New Epilepsy-focused Website At AES Annual Meeting. |
|
|
Dec 2, 2011 |
662 |
| Teva Announces Agreement with Ranbaxy Regarding Generic Lipitor[R]. |
|
|
Dec 1, 2011 |
720 |
| Ranbaxy Announces Launch of Atorvastatin, Generic Lipitor[R], in the U.S. |
|
Company overview |
Dec 1, 2011 |
519 |
| Mylan Launches Generic Version of Caduet Tablets. |
|
|
Dec 1, 2011 |
329 |
| Walmart Announces Generic Lipitor (Atorvastatin Calcium Tablets) Available in Stores Today. |
|
|
Dec 1, 2011 |
621 |
| Teva Announces Tentative Approval of Generic Lipitor[R]. |
|
|
Dec 1, 2011 |
780 |
| Benefits. |
|
|
Dec 1, 2011 |
3747 |
| HealthWarehouse.com Offers Lowest Price Generic Lipitor on the Market. |
|
|
Nov 29, 2011 |
826 |
| Watson's Generic Yaz(R) Receives FDA Approval. |
|
|
Nov 29, 2011 |
668 |
| Mylan Receives Approval for Generic Version of Zinecard for Injection. |
|
|
Nov 28, 2011 |
321 |
| Research and Markets: Heart Failure (HF) Therapeutics - Current HF Market is Weak and is Dominated by Generics. |
|
|
Nov 22, 2011 |
420 |
| Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot. |
|
|
Nov 21, 2011 |
491 |
| Impax Laboratories Confirms Patent Challenge Relating to Generic FENTORA[R]. |
|
|
Nov 21, 2011 |
719 |
| Amneal Launches Fluocinolone Acetonide Family for Skin and Ear Care. |
|
|
Nov 21, 2011 |
428 |
| Owing to the Generic Erosion of Key Agents, the Drug Market for Benign Prostatic Hyperplasia/Male Lower Urinary Tract Symptoms Will Decrease from More Than $4.8 Billion in 2010 to Just under $4 Billion in 2020. |
|
|
Nov 17, 2011 |
595 |
| Zacks Bull and Bear of the Day Highlights: Perrigo, Leggett & Platt, Citigroup, Bank of America and Bank of New York Mellon. |
|
|
Nov 17, 2011 |
1873 |
| Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $1.1 Billion in North Carolina. |
|
|
Nov 17, 2011 |
638 |
| Health Ministry slashes prices of hundreds of generic drugs. |
|
|
Nov 16, 2011 |
784 |
| Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $608 Million in Alabama. |
|
|
Nov 16, 2011 |
574 |
| Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $2.1 Billion in Florida. |
|
|
Nov 16, 2011 |
575 |
| Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $1 Billion in New Jersey. |
|
|
Nov 16, 2011 |
641 |
| Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $681 Million in Missouri. |
|
|
Nov 16, 2011 |
631 |
| Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $1.1 Billion in Michigan. |
|
|
Nov 16, 2011 |
634 |
| Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $1.4 Billion in Illinois. |
|
|
Nov 16, 2011 |
632 |
| The Outlook for Pharmaceuticals in Latin America. |
|
|
Nov 15, 2011 |
1891 |
| The Outlook for Pharmaceuticals in Central & Eastern Europe. |
|
|
Nov 15, 2011 |
1142 |
| FairWinds Partners Offers Full Suite of New gTLD Consulting Services to Help Brand Owners Navigate the New Generic Top-Level Domain Name (gTLD) Space. |
|
|
Nov 15, 2011 |
890 |
| Teva UK Limited Launches Generic Valsartan and Valsartan HCTZ. |
|
|
Nov 15, 2011 |
610 |
| Physician comment sought on opioid prescribing education program. |
Mechcatie, Elizabeth |
|
Nov 15, 2011 |
217 |
| IMS Study Reveals Drug Shortages in U.S. Disruptive Yet Narrowly Concentrated. |
|
|
Nov 14, 2011 |
917 |
| Ministry slashes generic drug prices. |
|
|
Nov 14, 2011 |
426 |
| Generic drug prices reduced by up to 30%. |
|
|
Nov 14, 2011 |
603 |
| Research and Markets: Multi-therapy Drugs: Opportunities for Generics & Biosimilars. |
|
|
Nov 14, 2011 |
393 |
| An Entrepreneurial Family: Chintu and Chirag Patel of Amneal Pharmaceuticals, LLC Named Ernst & Young National Entrepreneur Of The Year 2011 Life Sciences Award Winners. |
|
Awards list |
Nov 13, 2011 |
1358 |
| Actavis Launches Generic KADIAN Capsules in the U.S. |
|
|
Nov 11, 2011 |
380 |
| Research and Markets: Generics in the Netherlands. |
|
|
Nov 10, 2011 |
447 |
| Obama Back to Even With "Generic" Republican Candidate; Independents now evenly split after previously favoring the Republican. |
Newport, Frank |
Survey |
Nov 10, 2011 |
904 |
| Mylan Applauds Obama Administration's Call to Create an "AIDS-Free Generation" Through Global Fight Against HIV/AIDS. |
|
|
Nov 9, 2011 |
522 |
| Americans for Choice and Competition in Agriculture Launched to Address Choice, Competition, Innovation in the Agriculture Marketplace. |
|
|
Nov 9, 2011 |
425 |
| JCM Passes Internal Quality Assessment for Azithromycin API Production. |
|
|
Nov 9, 2011 |
604 |
| Research and Markets: The Pharmaceutical Market: South Africa. Enhanced Strategic Intelligence in a User-friendly Format. |
|
|
Nov 8, 2011 |
502 |
| Advising Medicare Beneficiaries - Medco's 2012 Medicare Prescription Drug Plan Helps Members Get the Most Value from Their Benefits. |
|
|
Nov 7, 2011 |
1144 |
| Generic Erosion of Key Agents, Will Cause the Hypertension Drug Market to Decline from Approximately $26 Billion in 2010 to $20.5 Billion in 2020. |
|
|
Nov 3, 2011 |
491 |
| TPI to Develop New Formulation for Flagship Product Gingko Mihuan. |
|
|
Nov 3, 2011 |
673 |
| Research and Markets: Consolidation in the Generic Pharmaceutical Industry; An Evolving Landscape. |
|
|
Nov 2, 2011 |
465 |
| Research and Markets: Generic Drug Product Development: Specialty Dosage Forms. |
|
|
Nov 2, 2011 |
219 |
| Research and Markets: APIs in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape. |
|
|
Nov 2, 2011 |
568 |
| Multi-therapy Drugs: Opportunities for Generics & Biosimilars. |
|
|
Nov 2, 2011 |
2925 |
| Perrigo Announces Launch of Generic Version of Elestat. |
|
|
Nov 1, 2011 |
586 |
| Painting by numbers: adding numbers, be they Dollars or percentages, to the debate on patent expiries and the progression of generics, paints a sobering reality. |
Robinson, Kevin |
|
Nov 1, 2011 |
869 |
| Business and Operation Excellence for Branded Generics Expansion Into Emerging Markets. |
|
|
Oct 28, 2011 |
420 |
| Research and Markets: How to Forecast Generic Pharmaceutical Prices: A Practical Methodology to Calculate Future Generic Product Prices. |
|
|
Oct 27, 2011 |
395 |
| Mylan Receives Approval for Generic Version of MS Contin Tablets. |
|
|
Oct 27, 2011 |
306 |
| Teva and Dr. Reddy's Announce Launch of Generic Zyprexa[R] in the United States. |
|
|
Oct 25, 2011 |
561 |
| INNOPHARMA Receives FDA Approval of Generic Olanzapine Injection. |
|
|
Oct 25, 2011 |
197 |
| FTC Study Finds that in FY 2011, Pharmaceutical Industry Continued to Make Numerous Business Deals that Delay Consumers' Access to Lower-Cost Generic Drugs. |
|
|
Oct 25, 2011 |
739 |
| Gov. Gregoire Thanks Doctors for Generics First Savings. |
|
|
Oct 25, 2011 |
594 |
| CPhI Global Portfolio Expands into South East Asia. |
|
|
Oct 25, 2011 |
621 |
| Mylan Launches First Generic Version of Exelon Capsules in the U.K. |
|
|
Oct 25, 2011 |
320 |
| The Breast Cancer Drug Market Will Increase Marginally over the Next Decade, Despite Generic and Biosimilar Erosion of Key Agents. |
|
|
Oct 25, 2011 |
789 |
| Teva and Dr. Reddy's Announce Launch of Generic Zyprexa[R] in the United States. |
|
|
Oct 25, 2011 |
898 |
| Research and Markets: Generics in China - The Market is Expected to Reach a Value of $32.7 Billion by the End of 2015, New Report Says. |
|
|
Oct 24, 2011 |
400 |
| Research and Markets: Generics in France. An Essential Resource for Top-line data and Analysis Out Now. |
|
|
Oct 24, 2011 |
399 |
| Research and Markets: Generics in Japan. Up-to-date Report With Forecasts to 2015 Out Now. |
|
|
Oct 24, 2011 |
405 |
| Research and Markets: Generics in Spain - Essential Resource for Top-line data and Analysis Out Now. |
|
|
Oct 24, 2011 |
407 |
| JCM Begins Operation and Aims for GMP certification in November. |
|
|
Oct 24, 2011 |
686 |
| FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder. |
|
|
Oct 24, 2011 |
694 |
| Boca Pharmacal Receives FDA Approval on Glycopyrrolate Tablets. |
|
|
Oct 21, 2011 |
481 |
| Through 2020, Growth in the Parkinson's Disease Drug Market Will Be Constrained by Generic Competition to Key Therapies. |
|
|
Oct 20, 2011 |
634 |
| Research and Markets: Generics in Belgium. Essential Resource for Top-line Data and Analysis Covering the Belgium Generics Market Out Now. |
|
|
Oct 20, 2011 |
469 |
| Companies & Markets: Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018. |
|
|
Oct 20, 2011 |
404 |
| Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals. |
|
|
Oct 19, 2011 |
1479 |
| Mylan Announces Femcon Fe Settlement Agreement. |
|
|
Oct 19, 2011 |
475 |
| Companiesandmarkets.com: Global Generics Market Bolstered by Value-Added 'Supergenerics'. |
|
Industry overview |
Oct 19, 2011 |
445 |
| Pharmacists to Federal Medicaid Officials: Revamp Proposed Generic Drug Federal Upper Limits to Preserve Pharmacy Access for Patients. |
|
|
Oct 19, 2011 |
1008 |
| CPhI India and Co-Located Events Offer Diverse Programme to Support the Growing Indian Pharma Market. |
|
Conference news |
Oct 18, 2011 |
766 |
| Amerigen Pharmaceuticals and Stason Pharmaceuticals Enter Into Collaboration Agreement for Development of Generic Oral Oncology Products. |
|
|
Oct 18, 2011 |
486 |
| Research and Markets: Generics: Global Industry Guide. Market Expected to Reach 79.8% of Total Pharma Volume By 2015. |
|
Industry overview |
Oct 17, 2011 |
361 |
| Research and Markets: Generics in Europe - Top-line qualitative and quantitative summary information. |
|
|
Oct 17, 2011 |
379 |
| Watson Confirms Atelvia(TM) Patent Challenge. |
|
|
Oct 17, 2011 |
724 |
| Research and Markets: Generics in Germany. An Essential Resource for Top-line data and Analysis Out Now. |
|
|
Oct 14, 2011 |
410 |
| Research and Markets: Generics in Asia-Pacific. An Essential Resource for Top-line Data and Analysis Out Now. |
|
|
Oct 14, 2011 |
393 |
| "Generic" Republican Continues to Lead Obama in 2012 Vote; Lead is 46% to 38% among registered voters. |
Jones, Jeffrey M. |
Survey |
Oct 14, 2011 |
875 |
| Noven Files Patent Infringement Lawsuit against Watson Pharmaceuticals. |
|
|
Oct 13, 2011 |
308 |
| Research and Markets: Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers. New Report Out Now. |
|
Industry overview |
Oct 10, 2011 |
357 |
| NCPA Digest Finds Independent Community Pharmacies Reducing Health Costs Through Generic Drug Use, Patient Counseling. |
|
|
Oct 10, 2011 |
1159 |
| Banner Announces Submission of Its First-to-File ANDA for Targretin[R]. |
|
|
Oct 10, 2011 |
379 |
| Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX. |
|
|
Oct 8, 2011 |
993 |
| Teva UK Limited Launches Generic Salmeterol (Salmeterol xinafoate) pMDI. |
|
|
Oct 7, 2011 |
442 |
| Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R). |
|
|
Oct 7, 2011 |
862 |
| Research and Markets: Global Oncology Drug Market: Strategic Assessments of Leading Suppliers. |
|
Industry overview |
Oct 6, 2011 |
322 |
| Despite Generic Availability of Five Other SSRIs, Physicians Commonly Prescribe Lexapro as a First-Line Treatment for GAD Patients. |
|
|
Oct 6, 2011 |
422 |
| Research and Markets: Global Infectious Disease Drug Market: Strategic Assessments of Leading Suppliers. |
|
Industry overview |
Oct 6, 2011 |
323 |
| Research and Markets: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers. |
|
Industry overview |
Oct 6, 2011 |
315 |
| Research and Markets: Global CNS Drug Market: Strategic Assessments of Leading Suppliers. |
|
Industry overview |
Oct 5, 2011 |
323 |
| Actavis Plans Latin America Expansion. |
|
|
Oct 5, 2011 |
541 |
| Research and Markets: North American Pharmaceutical Market: Strategic Assessments of Leading Suppliers. |
|
Industry overview |
Oct 4, 2011 |
329 |
| Alacrita Establishes Powerful Regulatory Affairs Practice to Serve Life Science Companies and Investors. |
|
|
Oct 3, 2011 |
1083 |
| JCM Receives the Approval for its Manufacturing Environmental Assessment. |
|
|
Oct 1, 2011 |
510 |
| New unlimited cyber real estate: they're making more, but should you buy it? It will take several years for the effect of the new generic top-level domains to fully play out. |
Amolsch, Regina; Plave, Lee |
|
Oct 1, 2011 |
1263 |
| Patents stymie access to vital nutrition. |
Bateman, Chris |
|
Oct 1, 2011 |
363 |
| Research and Markets: Generics in the United Kingdom - Performance of the Market Is Forecast To Decelerate, With an Anticipated CAGR Of 7.9% for the Five-Year Period 2010 - 2015. |
|
Industry overview |
Sep 30, 2011 |
380 |
| Research and Markets: The US Generics Market Had Total Revenue of $71.4 Billion in 2010, Representing A CAGR Of 8.2% between 2006 and 2010. |
|
|
Sep 30, 2011 |
374 |
| Safeguard Scientifics Co-Leads $21M Series C Financing for Putney. |
|
|
Sep 29, 2011 |
933 |
| AstraZeneca Enters Into a Settlement Agreement with Handa Pharmaceuticals regarding U.S. SEROQUEL XR[R] Patent Litigation. |
|
|
Sep 29, 2011 |
1256 |
| The Bipolar Disorder Drug Market Will Decline from $6.5 Billion in 2010 to $4 Billion in 2020, Owing Largely to Increasing Generic Competition within the Atypical Antipsychotic Drug Class. |
|
|
Sep 28, 2011 |
547 |
| Zacks Investment Ideas Feature Highlights: Watson Pharma, Teva Pharma and Perrigo. |
|
|
Sep 28, 2011 |
1113 |
| Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals. |
|
Industry overview |
Sep 23, 2011 |
1242 |
| Mylan Applauds Study Highlighting $931 Billion in Savings for U.S. Health Care System Due to Generic Drugs. |
|
|
Sep 22, 2011 |
662 |
| Owing to the Generic Erosion of Blockbuster Agents, the Unipolar Depression Drug Market Will Decrease from $11.6 Billion in 2010 to $9.8 Billion in 2020. |
|
|
Sep 22, 2011 |
536 |
| Watson Confirms Amphastar Patent Lawsuit. |
|
|
Sep 22, 2011 |
788 |
| Dr. Reddy's Announces the Launch of Rivastigmine Tartrate Capsules. |
|
|
Sep 22, 2011 |
378 |
| Property, rights, and the constitution of contemporary Indian biomedicine: notes from the Gleevec case. |
Rajan, Kaushik Sunder |
Essay |
Sep 22, 2011 |
7563 |
| Generic Drugs: The Global Market. |
|
Industry overview |
Sep 21, 2011 |
3668 |
| Market Share of Marketed Drugs to Face Erosion by Generic Alternatives: companiesandmarkets.com. |
|
|
Sep 19, 2011 |
441 |
| Generic Felbamate Now Available from Amneal. |
|
|
Sep 19, 2011 |
396 |
| TPI Provides Updates on the Renewal Application for High Tech Enterprise Status. |
|
|
Sep 19, 2011 |
708 |
| TPI Provides Updates on Jiangchuan Macrolide Facility. |
|
|
Sep 15, 2011 |
445 |
| Guidance on generic biologies. |
|
|
Sep 15, 2011 |
202 |
| 'Report Predicts Generic Drug Revenues Will Reach $137.6bn in 2015' Says Visiongain Analyst. |
|
Report |
Sep 14, 2011 |
1660 |
| Lupin Announces Launch of Generic KEPPRA XR Tablets. |
|
|
Sep 14, 2011 |
557 |
| Watson Launches Generic Keppra XR. |
|
|
Sep 13, 2011 |
673 |
| Research and Markets: Cancer Generics Market Analysis. |
|
|
Sep 13, 2011 |
410 |
| Impax Laboratories Confirms Patent Challenge Relating to Generic JALYN[R] 0.5 mg/0.4 mg. |
|
|
Sep 12, 2011 |
865 |
| Acorda Therapeutics Statement on ZANAFLEX CAPSULES[R] Patent Litigation. |
|
|
Sep 7, 2011 |
760 |
| Jefferies to Host 2011 Global Healthcare Conference in London. |
|
Conference news |
Sep 7, 2011 |
356 |
| Teva UK Limited Launches Generic Levetiracetam Tablets. |
|
|
Sep 7, 2011 |
539 |
| Sinphar, Daito tie up to develop anti-cancer generic drugs. |
Liang, Quincy |
Brief article |
Sep 7, 2011 |
204 |
| Therapeutic Proteins Market Dominated by Roche, Amgen and Novo Nordisk: companiesandmarkets.com. |
|
|
Sep 6, 2011 |
446 |
| Research and Markets: Market Access Brazil: Unlocking Pharma Potential. |
|
|
Sep 1, 2011 |
448 |
| Name game: generic-drug makers are shielded from failure-to-warn claims while brand name companies aren't. |
Post, Ashley |
|
Sep 1, 2011 |
1467 |
| FDA approves first generic versions of levofloxacin. |
|
Brief article |
Sep 1, 2011 |
141 |
| Lupin Receives Final Approval to Market Generic Ultram ER. |
|
|
Aug 31, 2011 |
572 |
| Impax Laboratories Confirms Patent Challenge Relating to Generic NUEDEXTA[R] 20 mg/10 mg. |
|
|
Aug 31, 2011 |
702 |
| Media Advisory: Interview Source for Story About Plea to FDA to Allow Generic Drug Makers to Update Labels. |
|
|
Aug 30, 2011 |
361 |
| Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%. |
|
|
Aug 30, 2011 |
611 |
| Medivir Subsidiary BioPhausia AB Sells Generics Business. |
|
|
Aug 26, 2011 |
365 |
| Managing Bioequivalence Studies to Optimize the Quality, Cost, and Speed of Generics Manufacturing. |
|
|
Aug 25, 2011 |
456 |
| Prime Therapeutics Drug Trend Insights Reports One of the Lowest Drug Spending Increases in the Industry. |
|
|
Aug 24, 2011 |
1254 |
| Simcere's Branded Generic Formulation Biqi Passes EU-GMP Inspection. |
|
|
Aug 23, 2011 |
547 |
| The Zacks Analyst Blog Highlights: Par Pharmaceutical Companies, Intellipharmaceutics International, Celgene Corporation, Novartis AG and Elan Corporation plc. |
|
|
Aug 22, 2011 |
1187 |
| Prasco Launches Authorized Generic with Shionogi Inc. |
|
|
Aug 22, 2011 |
466 |
| Leading Consumer Mobile Healthcare App iTriage Adds Medication Information Through a New, More User-Friendly Interface. |
|
|
Aug 19, 2011 |
451 |
| Research and Markets: Cambodia Pharmaceutical and Healthcare Report Q2 2011. |
|
Report |
Aug 14, 2011 |
427 |
| Mylan Launches Generic Version of Uroxatral Tablets. |
|
|
Aug 12, 2011 |
270 |
| Generic Drugs in Consumer Health Global Overview 2011. |
|
|
Aug 11, 2011 |
586 |
| Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents. |
|
|
Aug 11, 2011 |
1243 |
| Research and Markets: Strategic Analysis of Active Ingredients in Healthcare 2011 - Understand the Key Market Drivers, Major Players & Mega Trends Influencing the Industry. |
|
|
Aug 10, 2011 |
517 |
| RIGHT OF THE DOT and Architelos Join Forces to Offer Comprehensive Marketing, Valuation and Management Services for New TLD Applications. |
|
|
Aug 10, 2011 |
909 |
| Research and Markets: Chile Pharmaceuticals and Healthcare Report Q2 2011 - Out Now! |
|
Report |
Aug 9, 2011 |
288 |
| Research and Markets: Global Biopharma Outlook 2011: Japanese Pharma. |
|
|
Aug 8, 2011 |
454 |
| Vectura announces deal for its asthma treatment. |
|
|
Aug 6, 2011 |
331 |
| Amneal Announces Four New Generic Drugs. |
|
|
Aug 2, 2011 |
541 |
| A preliminary study on the reliability of the Malay version of the Quality of Life Inventory[TM] version 4.0 (PEDSQL) generic core scales among children with disabilities in Kelantan, Malaysia: Parent-proxy report. |
Rahman, Azriani Ab; Ariffin, Nor Hashimah; Musa, Kamarul Imran; Ibrahim, Wan Pauzi Wan; Ibrahim, Moh |
Report |
Aug 1, 2011 |
2960 |
| Redesigning Nebraska's libraries technical services: creating a climate for change. |
Pearson, Debra J.; Busch, Nancy J. |
Report |
Aug 1, 2011 |
6006 |
| Research and Markets: Hospital Injectable Drugs: Future Prospects for Generics & Biosimilars. |
|
|
Jul 29, 2011 |
483 |
| Generic Injectables Market Exceeds US$11.2 Billion, According to New Report: companiesandmarkets.com. |
|
Report |
Jul 28, 2011 |
436 |
| Research and Markets: Poland Pharmaceuticals & Healthcare Report Q3 2011 - Demand for Generic & Patented Medicines to Increase with Expanded Access to Healthcare. |
|
Report |
Jul 28, 2011 |
480 |
| Teva Announces Launch of Camrese[TM] the Authorized Generic of Seasonique [R]. |
|
|
Jul 28, 2011 |
735 |
| Watson Launches Generic Seasonique(R). |
|
|
Jul 28, 2011 |
754 |
| Research and Markets: Generic Drugs in Consumer Health Global Overview 2011. |
|
|
Jul 27, 2011 |
310 |
| Dr. Reddy's Announces the Launch of Gemcitabine for Injection. |
|
|
Jul 27, 2011 |
414 |
| Clean Earth Announces a New Generic Approvals Program at Clean Earth of North Jersey Facility. |
|
|
Jul 26, 2011 |
377 |
| New "Generic Drugs in Consumer Health Global Overview 2011" Now Available at MarketPublishers.com. |
|
|
Jul 25, 2011 |
411 |
| Prasco Announces Authorized Generic Agreement with Shionogi Inc. |
|
|
Jul 25, 2011 |
510 |
| Research and Markets: Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases. |
|
|
Jul 22, 2011 |
696 |
| Watson Confirms JALYN(TM) Patent Challenge. |
|
|
Jul 22, 2011 |
658 |
| Medco Delivers Second-Quarter 2011 GAAP Diluted EPS of $0.85, Up 10.4 Percent; Diluted EPS Excluding All Intangible Amortization of $0.96, Up 10.3 Percent. |
|
Financial report |
Jul 21, 2011 |
36466 |
| Boca Pharmacal Receives FDA Approval on Hydrocodone Bitartrate and Acetaminophen Oral Solution. |
|
|
Jul 21, 2011 |
459 |
| Actavis Launches Oxymorphone Hydrochloride Extended-Release Tablets, CII in the U.S. |
|
|
Jul 20, 2011 |
453 |
| Research and Markets: India Pharmaceuticals and Healthcare Report Q3 2011 - The Drugs Controller General of India Puts a Temporary Halt on Marketing Approvals for New Drugs. |
|
Report |
Jul 15, 2011 |
587 |
| PCMA Hails Introduction of Bipartisan Legislation to Increase the Use of Generic Drugs in Medicaid. |
|
|
Jul 15, 2011 |
428 |
| New Comprehensive GBI Research Reports Published by MarketPublishers.com. |
|
|
Jul 14, 2011 |
472 |
| Ranbaxy,Gilead Sciences to manufacture and market three anti-HIV drugs in India, developing nations. |
|
|
Jul 14, 2011 |
339 |
| Dr. Reddy's Laboratories gets USDA approval for Australian bioequivalent sodium injection. |
|
|
Jul 14, 2011 |
333 |
| Dr. Reddy's Announces the USFDA Approval of Fondaparinux Sodium Injection. |
|
|
Jul 13, 2011 |
721 |
| Japan and China Dominate Asian Active Pharmaceutical Ingredients Market: companiesandmarkets.com. |
|
Industry overview |
Jul 13, 2011 |
430 |
| Mylan Receives Voluntary License Rights to Gilead's HIV/AIDS Pipeline Products in Developing World. |
|
|
Jul 12, 2011 |
549 |
| Chartwell Pharmaceuticals Receives Official FDA Registration. |
|
|
Jul 12, 2011 |
254 |
| TPI Schedules Test Runs at Jiangchuan Macrolide Facility by End of July. |
|
|
Jul 8, 2011 |
651 |
